IL153847A0 - Method of producing infectious reovirus - Google Patents

Method of producing infectious reovirus

Info

Publication number
IL153847A0
IL153847A0 IL15384701A IL15384701A IL153847A0 IL 153847 A0 IL153847 A0 IL 153847A0 IL 15384701 A IL15384701 A IL 15384701A IL 15384701 A IL15384701 A IL 15384701A IL 153847 A0 IL153847 A0 IL 153847A0
Authority
IL
Israel
Prior art keywords
producing infectious
infectious reovirus
reovirus
producing
infectious
Prior art date
Application number
IL15384701A
Other languages
English (en)
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of IL153847A0 publication Critical patent/IL153847A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/765—Reovirus; Rotavirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15384701A 2000-08-10 2001-07-20 Method of producing infectious reovirus IL153847A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22402600P 2000-08-10 2000-08-10
PCT/CA2001/001054 WO2002012435A1 (en) 2000-08-10 2001-07-20 Method of producing infectious reovirus

Publications (1)

Publication Number Publication Date
IL153847A0 true IL153847A0 (en) 2003-07-31

Family

ID=22838987

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15384701A IL153847A0 (en) 2000-08-10 2001-07-20 Method of producing infectious reovirus
IL153847A IL153847A (en) 2000-08-10 2003-01-08 Method of producing infectious reovirus

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL153847A IL153847A (en) 2000-08-10 2003-01-08 Method of producing infectious reovirus

Country Status (18)

Country Link
US (4) US6528305B2 (de)
EP (2) EP1586634B1 (de)
JP (2) JP4009532B2 (de)
AR (1) AR033993A1 (de)
AT (2) ATE394475T1 (de)
AU (2) AU2001275628B2 (de)
BR (1) BR0113122A (de)
CA (1) CA2415749C (de)
DE (2) DE60133947D1 (de)
DK (2) DK1309672T3 (de)
ES (2) ES2305940T3 (de)
IL (2) IL153847A0 (de)
MX (1) MXPA03000846A (de)
NZ (1) NZ523510A (de)
PT (2) PT1309672E (de)
TW (1) TWI289158B (de)
WO (1) WO2002012435A1 (de)
ZA (1) ZA200300410B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545492B1 (en) * 1999-09-20 2003-04-08 Europaisches Laboratorium Fur Molekularbiologie (Embl) Multiple local probe measuring device and method
TWI289158B (en) * 2000-08-10 2007-11-01 Oncolytics Biotech Inc Method of producing infectious reovirus
DK2253701T3 (da) 2001-03-16 2014-10-20 Oncolytics Biotech Inc Fremgangsmåde til ekstraktion af en virus fra en cellekultur
US20040115170A1 (en) * 2001-11-30 2004-06-17 Brown Earl Garnet Oncolytic virus
CA2374388C (en) 2002-02-28 2005-07-12 Matthew C. Coffey The use of ribozymes in the detection of adventitious agents
US20040005546A1 (en) 2002-02-28 2004-01-08 Oncolytics Biotech Inc. Use of ribozymes in the detection of adventitious agents
CA2426283C (en) * 2002-04-29 2006-06-27 The Trustees Of The University Of Pennsylvania Method for direct rescue and amplification of integrated viruses from cellular dna of tissues
CA2482512C (en) * 2002-04-30 2011-09-20 Oncolytics Biotech Inc. Improved viral purification methods
EP1944035A1 (de) 2002-05-09 2008-07-16 Oncolytics Biotech Inc. Verfahren zur Schmerzlinderung durch onkolytische Viren
DE03722131T1 (de) * 2002-05-09 2005-09-15 Oncolytics Biotech, Inc., Calgary Methode zur schmerzbekämpfung mit onkolytischen viren
WO2003094939A1 (en) * 2002-05-10 2003-11-20 Oncolytics Biotech Inc. Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
US7901921B2 (en) 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
US7490608B2 (en) * 2005-06-17 2009-02-17 Nellcorr Puritan Bennett Llc System and method for adjusting a gas delivery mask
WO2007099401A2 (en) 2005-08-01 2007-09-07 University Technologies International, Inc. Oncolytic attenuated reoviruses for treatment of proliferative disorders
US10668119B2 (en) 2005-08-01 2020-06-02 Virocure, Inc. Attenuated reovirus
US20070190032A1 (en) * 2006-02-13 2007-08-16 Oncolytics Biotech Inc. Use of Local Immune Suppression to Enhance Oncolytic Viral Therapy
US8293498B2 (en) 2006-12-20 2012-10-23 Vanderbilt University System for generation of viable reovirus from cloned cDNA
WO2008127486A2 (en) * 2006-12-29 2008-10-23 Bacilligen, Inc. Replication-proficient dsrna capsids and uses thereof
JP5577103B2 (ja) * 2007-03-12 2014-08-20 オンコリティクス バイオテク，インコーポレーテッド 改変配列を有するレオウイルス
US10369171B2 (en) 2007-03-13 2019-08-06 Virocure, Inc. Attenuated reoviruses for selection of cell populations
AR066649A1 (es) * 2007-05-21 2009-09-02 Oncolytics Biotech Inc Reovirus mutantes y metodos de elaboracion y uso de los mismos
EP2211880A4 (de) * 2007-10-22 2012-11-14 Oncolytics Biotech Inc Behandlungsverfahren für proliferative erkrankungen
MX339014B (es) * 2008-05-27 2016-05-09 Oncolytics Biotech Inc Modulacion de presion intersticial y suministro y distribucion viral oncolitica.
TW200950777A (en) * 2008-05-27 2009-12-16 Oncolytics Biotech Inc Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
WO2011126976A1 (en) 2010-04-07 2011-10-13 Vanderbilt University Reovirus vaccines and methods of use therefor
US9644187B2 (en) 2010-04-14 2017-05-09 Emd Millipore Corporation Methods of producing high titer, high purity virus stocks and methods of use thereof
AU2011336413B2 (en) 2010-12-02 2015-01-22 Oncolytics Biotech Inc. Liquid viral formulations
MX349294B (es) 2010-12-02 2017-07-21 Oncolytics Biotech Inc Formulaciones virales liofilizadas.
WO2015070323A1 (en) 2013-11-15 2015-05-21 Oncolytics Biotech Inc. Oncolytic viruses and increased cancer treatment regimens
CN112143693B (zh) * 2019-06-28 2024-12-27 杭州康万达医药科技有限公司 一种生产病毒的方法及收获液组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070453A (en) * 1976-06-25 1978-01-24 Syntex (U.S.A.) Inc. Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines
US4559229A (en) * 1982-07-20 1985-12-17 Research Foundation Avian proventriculitis vaccine
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
JPS6344532A (ja) 1986-08-11 1988-02-25 Biseibutsu Kagaku Kenkyusho:Kk 豚のレオウイルス感染症ワクチン
US5658779A (en) 1992-03-20 1997-08-19 Ligochem, Inc. Method of adsorbing viruses from fluid compositions
JPH08214876A (ja) 1995-02-15 1996-08-27 Chemo Sero Therapeut Res Inst ウイルスの調製法
ES2278399T3 (es) 1996-11-20 2007-08-01 Introgen Therapeutics, Inc. Metodo mejorado para la produccion y purificacion de vectores adenovirales.
CA2283894A1 (en) 1997-06-24 1998-12-30 Basf Aktiengesellschaft Method for producing 4,4' dihalogendiphenylsulfone
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US6136307A (en) * 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
AR028039A1 (es) 2000-05-03 2003-04-23 Oncolytics Biotech Inc Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
TWI289158B (en) * 2000-08-10 2007-11-01 Oncolytics Biotech Inc Method of producing infectious reovirus

Also Published As

Publication number Publication date
EP1309672A1 (de) 2003-05-14
DE60111747D1 (de) 2005-08-04
US20040126869A1 (en) 2004-07-01
EP1586634A1 (de) 2005-10-19
AR033993A1 (es) 2004-01-21
ZA200300410B (en) 2004-01-26
US6703232B2 (en) 2004-03-09
DK1309672T3 (da) 2005-10-10
US7429485B2 (en) 2008-09-30
PT1309672E (pt) 2005-09-30
US6528305B2 (en) 2003-03-04
ATE298788T1 (de) 2005-07-15
DK1586634T3 (da) 2008-08-18
AU2001275628B8 (en) 2002-02-18
AU7562801A (en) 2002-02-18
US7049127B2 (en) 2006-05-23
DE60111747T2 (de) 2006-04-27
IL153847A (en) 2007-10-31
ES2241844T3 (es) 2005-11-01
DE60133947D1 (de) 2008-06-19
JP4009532B2 (ja) 2007-11-14
CA2415749A1 (en) 2002-02-14
ES2305940T3 (es) 2008-11-01
BR0113122A (pt) 2003-07-22
PT1586634E (pt) 2008-06-19
WO2002012435A1 (en) 2002-02-14
EP1586634B1 (de) 2008-05-07
TWI289158B (en) 2007-11-01
NZ523510A (en) 2004-08-27
AU2001275628B2 (en) 2007-08-30
US20030166253A1 (en) 2003-09-04
US20060165724A1 (en) 2006-07-27
US20020037576A1 (en) 2002-03-28
EP1309672B1 (de) 2005-06-29
ATE394475T1 (de) 2008-05-15
CA2415749C (en) 2009-05-12
JP2004505623A (ja) 2004-02-26
JP2006314336A (ja) 2006-11-24
HK1082765A1 (en) 2006-06-16
MXPA03000846A (es) 2004-04-05

Similar Documents

Publication Publication Date Title
IL153847A0 (en) Method of producing infectious reovirus
AU4299501A (en) Method of producing profiled sheets as prosthesis
IL200255A (en) Method of preparing o-desmethyl-venlafaxine
PL353369A1 (pl) Sposób wytwarzania czystego citalopramu
PL365912A1 (en) Method for producing honeycomb structure
GB0028021D0 (en) Method of fabricating structures
EG23110A (en) Method of producing polymeric filaments
IL156791A0 (en) Manufacturing method of combined vaccine
PL361146A1 (en) Method for producing isocyanato-organosilanes
HUP0102967A3 (en) Method for producing organosilylalkyl-polysulphanes
PL360934A1 (en) Method of purifying plavastatin
EP1264961A4 (de) Verfahren zur ölproduktion
AU2002231683A1 (en) Method of producing alk-3-ene-1-ols
PL346034A1 (en) Method of obtaining substituted banzoylcyanide aminohydrazones
EP1278817A4 (de) Verfahren zur herstellung einer silberhaltigen kerze
EP1258331A4 (de) Verfahren zum herstellen von keramischen strukturen
HU0104563D0 (en) Process for producing of food-enzymes
AU7265900A (en) Method for producing otoplastics
AU8626801A (en) Method of forming complex
GB0000411D0 (en) Method of producing lamps
GB0014407D0 (en) Method of producing cast calots
PL344651A1 (en) Method of obtaining 4-demethoxydaunomycinone
PL344228A1 (en) Method of obtaining paclitaxtel
PL344809A1 (en) Method of obtaining n-tert-butoxycarbonyl-l-ornitin
HUP0301741A3 (en) Method for producing 4-bromine-aniline derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed